Home › Therapeutic areas › Neurology › Substance Use Disorder
Substance Use Disorder (3 companies)
Companies with an active program in Substance Use Disorder.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| ALT | Altimmune | GI/HepatologyMetabolic+1 | 1 | Phase 3 | $405M | 3 |
| ATAI | Atai Beckley | Neurology | 1 | Phase 2 | $2.73B | 5 |
| HELP | Helus Pharma | Neurology | 1 | Phase 3 | $655M | 3 |
No companies match.